These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6653062)

  • 21. Investigation of how different filters affect some biochemical properties of stored platelet concentrates.
    Järemo P; Kutti J
    Eur J Haematol; 1992 Jul; 49(1):25-8. PubMed ID: 1499695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Leucocyte removal prior to study of erythrocyte deformability.
    Stuart J; Kenny MW; Meakin M; Lucas GS; Caldwell NM
    Biorheology Suppl; 1984; 1():283-5. PubMed ID: 6591987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study on the use of leucocyte-filters in reducing blood transfusion reactions in multi-transfused thalassemic children.
    Tan KK; Lee WS; Liaw LC; Oh A
    Singapore Med J; 1993 Apr; 34(2):109-11. PubMed ID: 8266145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukocyte removal filtration of platelet concentrates. A study of platelet loss using 111In-labelled platelets and dynamic gamma camera scintigraphy.
    Wadenvik H; Kutti J; Lindholm A
    Eur J Haematol; 1991 Sep; 47(3):192-6. PubMed ID: 1915802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of leucocyte poor blood. A comparison of five different methods.
    Grunnet N; Rasmussen NJ
    Scand J Urol Nephrol Suppl; 1981; 64():106-11. PubMed ID: 6959257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of non-hemolytic transfusion reactions with leucocyte-poor blood: a prospective study.
    Reverberi R; Ferrari L; Gennari M; Menini C
    Haematologica; 1989; 74(3):283-8. PubMed ID: 2511098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Use of leukocyte-filtered, cytomegalovirus-antibody negative and irradiated cellular blood products].
    Solheim BG; Albrechtsen DH; Evensen SA; Leivestad T
    Tidsskr Nor Laegeforen; 1990 Jan; 110(1):42-5. PubMed ID: 2154061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic cytapheresis].
    Wiebecke D; Gunzer U; Ullrich H; Kadar J
    Beitr Infusionsther; 1991; 28():226-32. PubMed ID: 1725627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on leucocyte depletion of blood components by filtration.
    Pietersz RN; van der Meer PF; Seghatchian MJ
    Transfus Sci; 1998 Dec; 19(4):321-8. PubMed ID: 10351145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocyte depletion for safe blood transfusion.
    Singh S; Kumar A
    Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multistate cluster of red blood cell transfusion reactions associated with use of a leucocyte reduction filter.
    Alvarado-Ramy F; Kuehnert MJ; Alonso-Echanove J; Sledge L; Haley NR; Epstein J; Vostal J; Pearson M
    Transfus Med; 2006 Feb; 16(1):41-8. PubMed ID: 16480438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The preparation of red cells depleted of leukocytes. Review and evaluation.
    Meryman HT; Hornblower M
    Transfusion; 1986; 26(1):101-6. PubMed ID: 3945994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Leucocyte removal and its clinical application].
    Zhao SM; Lin WC; Liu JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Oct; 10(5):478-82. PubMed ID: 12513754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of platelet activation and membrane glycoprotein Ib and IIb-IIIa expression after filtration through three different leukocyte removal filters.
    Bertolini F; Rebulla P; Porretti L; Sirchia G
    Vox Sang; 1990; 59(4):201-4. PubMed ID: 2293458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving blood transfusion safety in resource-poor countries: a case study of using leucocyte reduced blood in Uganda.
    Dhabangi A; Musisi E; Kyeyune D
    Afr Health Sci; 2020 Jun; 20(2):977-983. PubMed ID: 33163066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of microaggregate filtration in the prevention of febrile transfusion reactions.
    Schned AR; Silver H
    Transfusion; 1981; 21(6):675-81. PubMed ID: 7314215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The in vitro evaluation of two filters (Erypur and Imugard IG 500) for white cell-poor platelet concentrates.
    Brubaker DB; Romine CM
    Transfusion; 1988; 28(4):383-5. PubMed ID: 3388485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inline-filtration.
    Karger R; Kretschmer V
    Transfus Apher Sci; 2002 Oct; 27(2):137-52. PubMed ID: 12350049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative efficiency of leucocyte removal procedures for the production of leucocyte-poor red cell concentrates assessed by flow cytometry.
    Farrugia A; Tan Y; Romeo A; Martin L; Rolland JR; Kellner S; Piouronowski H
    Vox Sang; 1994; 66(3):153-60. PubMed ID: 8036782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of red blood cell alloimmunization risk factors in multiply transfused thalassemia patients: role in improving thalassemia transfusion practice in Fayoum, Egypt.
    Abdelrazik AM; Elshafie SM; El Said MN; Ezzat Ahmed GM; Al-Gamil AK; El Nahhas MG; Sady AA
    Transfusion; 2016 Sep; 56(9):2303-7. PubMed ID: 27351342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.